Holger Klein

Senior Principal Scientist Computational Biology, Boehringer Ingelheim

Holger Klein specialises in turning high-dimensional omics data into therapeutic targets. Having lived and worked in both Germany and the US, and across academia and the private sector, he thrives at the intersection of cross-functional leadership and computational biology and data science applications in pharma.